Significance of oncogenes and tumor suppressor genes in AML prognosis. - Wikidata - awgldk - TriplyDB

Significance of oncogenes and tumor suppressor genes in AML prognosis.

Significance of oncogenes and tumor suppressor genes in AML prognosis.

http://www.wikidata.org/entity/Q30250315

about

Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis Voltage-gated calcium channels: Novel targets for cancer therapy.OPN b and c Isoforms Doubtless Veto Anti-angiogenesis Effects of Curcumin in Combination with Conventional AML Regiment Targeted sequencing reveals genetic variants associated with sensitivity of 79 human cancer xenografts to anticancer drugs.Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment.

P2860

Q37702629-5FA6D59E-05BA-45FE-9EF6-DC98CD46D7D7 Q39350173-576A317A-8C48-454E-A1A9-C70C14AD2565 Q41145371-B49E3A14-62C7-438C-90CA-F5490DE5A9A7 Q47149829-0D9447D9-D5C9-48D6-88A1-C6C4A1E709E2 Q49446395-1CDD9491-A951-479F-A66D-49F03A56A999 Q54917620-9D65E444-2E98-4935-86EB-426762F68799 Q55250417-79C00EEC-2003-44B4-9C6D-2007E757A6CE

P2860

Significance of oncogenes and tumor suppressor genes in AML prognosis.

http://www.wikidata.org/entity/Q30250315

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Significance of oncogenes and tumor suppressor genes in AML prognosis.

@ast

Significance of oncogenes and tumor suppressor genes in AML prognosis.

@en

type

label

Significance of oncogenes and tumor suppressor genes in AML prognosis.

@ast

Significance of oncogenes and tumor suppressor genes in AML prognosis.

@en

prefLabel

Significance of oncogenes and tumor suppressor genes in AML prognosis.

@ast

Significance of oncogenes and tumor suppressor genes in AML prognosis.

@en

P1433

Q30250315-9AAA0D49-6990-49CD-B5C5-FCDA24F581E5

P1476

Q30250315-0F12DB19-5D03-4337-80D8-E7B15B4DA613

P2093

Q30250315-5A1D2B0B-45A5-4DFF-8242-3EA6784D4503

Q30250315-E9994746-8B73-4137-A141-89635861984D

P2860

Q30250315-00F2595E-5A9E-48D7-B31C-6A601F661ABB

Q30250315-0131D7F2-A561-43F5-83E8-D2C104668F09

Q30250315-01A1A9FC-F298-4852-9FDB-2A23E69B9374

Q30250315-01C1152E-414A-4E4D-971A-8E870123F0AF

Q30250315-02BA2FB5-8E8A-46B8-84FE-0F4236883E05

Q30250315-0377DA95-7265-4486-B75F-789DBECC55B6

Q30250315-03CC91D3-DEE9-469C-A33C-2A8967DF2C23

Q30250315-07CF548F-1D68-4623-B060-F2CA94F83ED0

Q30250315-0B879AD3-937B-4B69-AEC3-DAF2A7627EEB

Q30250315-0E0A5CA3-8BA1-42F2-BB25-B5BD4521582E

P2888

Q30250315-6B0BF15E-9D90-492A-8E6A-CC8861AF6D34

P304

Q30250315-0909CB9F-D053-4AAA-A606-A810A14122FE

P31

Q30250315-42a5e541-6ba6-495c-93db-dee3ffde1926

Q30250315-CC809D18-12D5-4318-9528-7FB38B037D76

P356

Q30250315-CED8B44C-692B-4CB6-887B-A7D472B2495C

P433

Q30250315-A4A76F50-ADCB-40D5-B7BB-A0F4AAC80338

P478

Q30250315-F2A49F1B-3D88-4A46-8F05-ADB6591B4895

P50

Q30250315-65497754-B295-4176-8C9C-1B026167B0C7

Q30250315-CE6FB201-8E2F-48DA-ABBD-D68F879523D1

P577

Q30250315-CBB8B97B-A2F1-4FCC-A3EA-B33A05C8E5E8

P6179

Q30250315-69A60191-1F52-42C7-8418-C2321B084075

P698

Q30250315-9C07EB28-F9BD-4D39-BD12-0771A7896707

P356

S13277-016-5067-1

P1433

P1476

Significance of oncogenes and tumor suppressor genes in AML prognosis

@en

P2093

Maria Kavianpour

http://www.w3.org/2001/XMLSchema#string

Saeid Shahrabi

http://www.w3.org/2001/XMLSchema#string

P2860

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

MN1, a novel player in human AML

Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells

DNMT3A Mutations in Acute Myeloid Leukemia

FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.

Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

P2888

s13277-016-5067-1

P304

10041-10052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-5067-1

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Ahmad Ahmadzadeh

P577

2016-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039992691

http://www.w3.org/2001/XMLSchema#string

P698

27179964

http://www.w3.org/2001/XMLSchema#string